
    
      [18F]FTP is a novel radioactive tracer that has shown potential in labeling dopamine D3
      receptors through PET/CT imaging. This is a phase 1 study design meant to evaluate safety,
      biodistribution and brain uptake of [18F]FTP in healthy volunteers.
    
  